基层医疗尿路感染中抗生素耐药、耐药基因与治疗反应的相互作用
新加坡2015至2016年前瞻性研究纳入695例基层医疗尿路感染症状患者,299例尿培养阳性,大肠埃希菌占76%。肠杆菌科分离株对阿莫西林-克拉维酸、呋喃妥因和磷霉素高度敏感,但超过20%对环丙沙星和复方磺胺甲噁唑耐药;给予敏感抗生素者早期症状缓解率67%,显著高于不敏感者45%和未治疗者27%。
要点
- 基层尿路感染大肠埃希菌最常见,对磷霉素、呋喃妥因和阿莫西林-克拉维酸敏感性高。
- 超过20%肠杆菌科分离株对环丙沙星和复方磺胺甲噁唑耐药。
- 经验性选用敏感抗生素者早期症状缓解率更高,但体外敏感性与临床反应不完全一致。
核心结论
- 给予活性经验性抗生素的患者最可能报告早期症状缓解,但体外敏感性与临床反应的相关性并不完美。
- 与耐药相关的因素可指导是否进行初始尿培养的决策。
研究设计与样本
- 前瞻性研究,纳入2015至2016年新加坡基层医疗有尿路感染症状且尿培养确诊的患者。
- 695例有症状患者中299例尿培养阳性,其中259例(87%)为女性。
- 对肠杆菌科分离株(n=283)分析抗菌药物敏感性,并评估早期症状缓解与处方抗生素及分离株敏感性的关系。
主要发现
- 大肠埃希菌是最常见尿路病原体(76%)。
- 肠杆菌科分离株对阿莫西林-克拉维酸敏感率86%、呋喃妥因87%、磷霉素98%,但对环丙沙星和复方磺胺甲噁唑耐药率超过20%。
- 对指示抗生素耐药的分离株中,blaCTX-M阳性14/26(54%),质粒介导ampC阳性12/24(50%),qnr阳性7/69(10%),fos阳性1/6(17%)。
- 给予敏感抗生素的患者中67%报告早期缓解,给予不敏感抗生素者45%(P=0.001),未治疗者27%(P=0.018)。
- 多变量分析显示,印度裔和糖尿病与阿莫西林-克拉维酸耐药相关;泌尿生殖系统异常、过去12个月尿路感染和过去6个月住院与环丙沙星及复方磺胺甲噁唑耐药相关。
临床怎么用
- 基层尿路感染经验性治疗可考虑当地耐药谱,磷霉素、呋喃妥因和阿莫西林-克拉维酸敏感性较高。
- 对有耐药相关因素(如糖尿病、近期尿路感染或住院、泌尿生殖系统异常)的患者,可考虑初始尿培养指导治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Given increasing antimicrobial resistance, we aimed to determine antibiotic susceptibility and presence of resistance genes in uropathogens in primary care, factors associated with resistance to commonly prescribed antibiotics, and effect of treatment on early symptom resolution. We conducted a prospective study of primary care patients with urinary tract infection (UTI) symptoms and culture-confirmed UTI in Singapore from 2015 to 2016. Cohort characteristics and antimicrobial susceptibility of cultured isolates were analyzed. Among Enterobacteriaceae isolates, early symptom resolution (within 3 days) according to antibiotic prescribed and isolate susceptibility and factors associated with antibiotic resistance were evaluated. Of 695 symptomatic patients, 299 were urine culture positive; of these 299 patients, 259 (87%) were female. Escherichia coli was the most common uropathogen (76%). Enterobacteriaceae isolates (n = 283) were highly susceptible to amoxicillin-clavulanate (86%), nitrofurantoin (87%), and fosfomycin (98%), but >20% were resistant to ciprofloxacin and co-trimoxazole. Isolates resistant to appropriate indicator antibiotics were further tested to determine proportions positive for blaCTX-M (14/26, 54%), plasmid-mediated ampC (12/24, 50%), qnr (7/69, 10%), and fos (1/6, 17%) resistance genes. A total of 67% of patients given antibiotics with susceptible isolates reported early resolution versus 45% given antibiotics with nonsusceptible isolates (P = 0.001) and 27% not treated (P = 0.018). On multivariable analysis, Indian ethnicity and diabetes mellitus were associated with amoxicillin-clavulanate resistance. Genitourinary abnormalities, UTI in the past 12 months, and hospitalization in the past 6 months were associated with ciprofloxacin and co-trimoxazole resistance. Patients given active empirical antibiotics were most likely to report early symptom resolution, but correlation with in vitro susceptibility was imperfect. Factors associated with resistance may guide the decision to obtain initial urine culture.
引用
- Ho HJ, Tan MX, Chen MI, et al. Interaction between Antibiotic Resistance, Resistance Genes, and Treatment Response for Urinary Tract Infections in Primary Care. J Clin Microbiol. 2019. PMID: 31243084. doi:10.1128/JCM.00143-19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。